This multicentre, randomised, double-blind, placebo-controlled trial enrolled 2569 patients with reduced left ventricular function (ejection fraction <35%) and symptomatic heart failure.
The addition of enalapril to the conventional heart failure therapy was found to significantly:
Reference:
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page